In our reported case, the presence of the EWSR1-CREB1 gene fusion was confirmed via next-generation sequencing.The presence of this gene fusion could potentially be targeted for pharmaceutical intervention, providing a basis for further investigation into the management of PPMS. Here, EWSR1 is linked to primary progressive multiple sclerosis.